Your Life your connection to The Boston Globe
White Coat Notes: News from the Boston-area medical community
Send your comments and tips to

Elizabeth Cooney is a health reporter for the Worcester Telegram & Gazette.
Boston Globe Health and Science staff:
Scott Allen
Alice Dembner
Carey Goldberg
Liz Kowalczyk
Stephen Smith
Colin Nickerson
Beth Daley
Karen Weintraub, Deputy Health and Science Editor, and Gideon Gil, Health and Science Editor.
 Short White Coat blogger Ishani Ganguli
 Short White Coat blogger Jennifer Srygley
Week of: November 11
Week of: November 4
Week of: October 28
Week of: October 21
Week of: October 14
Week of: October 7

« Insuring the uninsured | Main | Appeals judge will hear nursing med student's plea for more break time »

Friday, September 21, 2007

Today's Globe: no Caritas sale, drugs costs, biotech drug debate, 9/11 clinics

The Archdiocese of Boston was unable for a second time to sell its troubled Caritas Christi Health Care, according to industry officials, jeopardizing the ability of New England's second largest hospital chain to offer top-flight medical care.

As overall healthcare costs continue to rise sharply, prescription drugs have emerged as a surprising exception.

The bill Congress is soon expected to pass giving regulators more authority over pharmaceutical companies is most significant to biotech drug makers and their would-be generic rivals because of what was left out. Generic drug makers such as Teva Pharmaceutical Industries Ltd. and Barr Pharmaceuticals failed to persuade lawmakers to attach legislation that would allow them to market generic versions of biotech drugs produced by the likes of Amgen Inc. and Genentech Inc.

Two free New York City health clinics devoted to the treatment of thousands of individuals made ill by toxic materials dispersed during the Sept. 11, 2001, terrorist attack on the World Trade Center opened yesterday.

Posted by Elizabeth Cooney at 06:54 AM
Sponsored Links